Skip to main content

Estimation of in vivo capillary or venous blood glucose concentration from analysis on stored venous blood or its plasma and use in quality control of near-patient glucose tests.

Felding P, Jensen I, Linnet K, Manford G

Publication: Scand J Clin Lab Invest (2002) • Vol 62 • Page 201-10PMID: 12088339View on PubMed

Purpose

The purpose of this paper was to determine the effects of patient fasting, blood collection method/location, using plasma versus whole blood and storage duration on measurement of glucose.

Conclusion

Using heparin-fluoride venous blood, plasma glucose was 11.8-12.7% higher than whole blood glucose measurements. In non-fasting patients, capillary whole blood glucose was 12% higher than venous whole blood glucose, but in fasting patients, this difference was only 1.6%. Glucose levels in heparin-fluoride venous blood decreased by 6% and 7% in the first 2 h (non-fasting patient) and 4 h (fasting patient) of storage at 4-20 degrees C, respectively, and levels decreased by 9% and 10% after 24 h at 4 or 20 degrees C, respectively. The authors were able to use regression analysis to accurately correct for delayed analysis of glucose in whole blood or plasma.

Studies (1)

Purpose

The purpose of this study was to determine the effects of patient fasting, blood collection method/location, using plasma versus whole blood and storage duration on measurement of glucose. Capillary blood was collected into microcentrifuge tubes containing haemolysing and glucose stabilizing solutions or sodium-fluoride capillary tubes, and blood or plasma was stored at 4-20 degrees C for less than 4 h before freezing. Heparin-fluoride venous blood was stored at 4-20 degrees C for 2 h (non-fasting only) or 4 h (fasting only) before being stored at 20 degrees C. After storage, blood was diluted with haemolysing and glucose stabilizing solutions or centrifuged to obtain plasma before freezing.

Summary of Findings

Using heparin-fluoride venous blood, plasma glucose was 11.8-12.7% higher than whole blood glucose measurements. In non-fasting patients, capillary whole blood glucose was 12% higher than venous whole blood glucose, but in fasting patients, this difference was only 1.6%. Glucose levels in heparin-fluoride venous blood decreased by 6% and 7% in the first 2 h (non-fasting patient) and 4 h (fasting patient) of storage at 4-20 degrees C, respectively, and levels decreased by 9% and 10% after 24 h at 4 or 20 degrees C, respectively. The authors were able to use regression analysis to accurately correct for delayed analysis of glucose in whole blood or plasma. Capillary blood and plasma glucose were strongly correlated with venous plasma glucose (r=0.986, both).

  • Biospecimens

    FluidBlood
    FluidPlasma
  • Preservation Types

    Frozen
  • Diagnoses

    Not specified
  • Platforms

    CarbohydrateClinical chemistry/auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionPatient diet
    Fasting
    Non-fasting
    Biospecimen AcquisitionAnatomical location of blood draw
    Capillary
    Vein
    Biospecimen AcquisitionMethod of fluid acquisition
    Finger/heel prick sampling
    Venipuncture
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Whole blood
    Biospecimen Aliquots and ComponentsCentrifugation
    Centrifugation delays investigated
    StorageStorage duration
    0 h
    2 h
    24 h
    4 h
    <4 h
    StorageStorage temperature
    20 degrees C
    4 degrees C
    4-20 degrees C